Antiphospholipid antibodies and coagulation defects in women with implantation failure after IVF and recurrent miscarriage

Reproductive BioMedicine Online

Volumn 13, Issue 1, 2006, Pages 29-37

  Stern, Catharyn ^a   Chamley, Larry ^b  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Antiphospholipid antibodies; Implantation failure; IVF; Recurrent spontaneous abortion; Thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING DISORDER; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; DATA ANALYSIS; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HYPERCOAGULABILITY; MEDICAL ASSESSMENT; NIDATION; NONHUMAN; PATHOGENESIS; RECURRENT ABORTION; SYSTEMATIC REVIEW; THROMBOPHILIA; TREATMENT FAILURE;

EID: 33745961374     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)62013-5     Document Type: Conference Paper

References (96)

1. Adler RR, Ng AK, Rote NS 1995 Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biology of Reproduction 53, 905-910.
2. Amengual O, Atsumi T, Khamashta MA 2003 Tissue factor in antiphospholipid syndrome: shifting the focus from coagulation to endothelium. Rheumatology (Oxford) 42, 1029-1031.
3. Azem F, Many A, Ben Ami I et al. 2004 Increased rates of thrombophilia in women with repeated IVF failures. Human Reproduction 19, 368-370.
4. Bakimer R, Fishman P, Blank M et al. 1992 Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). Journal of Clinical Investigation 89, 1558-1563.
5. Balasch J, Reverter JC, Fabregues F et al. 1997 First repeated abortion is not associated with activated protein C resistance. Human Reproduction 12, 1094-1097.
6. Bare SN, Poka R, Balogh I et al. 2000 Factor V Leiden as a risk factor for miscarriage and reduced fertility. Australian and New Zealand Journal of Obstetrics and Gynaecology 40, 186-190.
7. Bertina RM, Koeleman BP, Koster T et al. 1994 Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64-67.
8. Bevers EM, Galli M 1990 Beta 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet 336, 952-953.
9. Birdsall MA, Lockwood GM, Ledger WL et al. 1996 Antiphospholipid antibodies in women having in vitro fertilization. Human Reproduction 11, 1185-1189.
10. Birkenfeld A, Mukaida T, Minichiello L et al. 1994 Incidence of autoimmune antibodies in failed embryo transfer cycles. American Journal of Reproductive Immunology 31, 65-68.
11. Branch DW, Dudley DJ, Mitchell MD et al. 1990 Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/ c mice: a model for autoimmune fetal loss. American Journal of Obstetrics and Gynecology 163, 210-216.
12. Branch WD, Hatasaka HH 1998 Antiphospholipid antibodies and infertility: Fact or fallacy. Lupus 7 (Suppl. 2), 90-94.
13. Buckingham KL, Stone PR, Smith JF, Chamley LW 2006 Antiphospholipid antibodies in serum and follicular fluid - is there a correlation with IVF implantation failure? Human Reproduction, 21, 728-734.
14. 2 glycoprotein I is the antigen for anticardiolipin autoantibodies. Clinical and Experimental Immunology 115, 571-576.
15. 2 glycoprotein I on trophoblast proliferation as a mechanism for fetal death. Lancet 352, 1037-1038.
16. Chamley LW, Pattison NS, McKay EJ 1994 The effect of human anticardiolipin antibodies on murine pregnancy. Journal of Reproductive Immunology 27, 123-134.
17. Chamley LW, McKay EJ, Pattison NS 1991 Cofactor dependent and cofactor independent anticardiolipin antibodies. Thrombosis Research 61, 291-299.
18. Chamley LW, Pattison NS, McKay EJ 1990 IgM lupus anticoagulants can be associated with fetal loss and thrombotic episodes. Thrombosis Research 57, 343-347.
19. Coulam CB 1991 Epidemiology of recurrent spontaneous abortion. American Journal of Reproductive Immunology 26, 23-27.
20. Coulam C, Kaider B, Janowicz P et al. 1997 Antiphospholipid antibodies associated with implantation failure after IVF/ET. Journal of Assisted Reproductive Genetics 14, 603-606.
21. Cowchock S, Smith JB, Gocial S 1986 Antibodies to phospholipids and nuclear antigens in patients with related abortions. American Journal of Obstetrics and Gynecology 155, 1002-1010.
22. Denis AL, Guido M, Adler RD et al.1997 Antiphospholipid antibodies and pregnancy rates and outcome in IVF patients. Fertility and Sterility 67, 1084-1090.
23. 2-glycoprotein I. Arthritis and Rheumatism 43, 140-150.
24. Di Simone N, Caliandro D, Castellani R et al. 1999 Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Human Reproduction 14, 489-495.
25. Di Simone N, De Carolis S, Lanzone A et al. 1995 In vitro effect of antiphospholipid antibody-containing sera on basal and gonadotrophin releasing hormone-dependent human chorionic gonadotrophin release by cultured trophoblast cells. Placenta 16, 75-83.
26. El Roeiy A, Gleicher N 1988 Definitions of normal antibody levels in an apparently healthy population. Obstetrics and Gynecology 77, 596-602.
27. El-Roeiy A, Gleicher N et al. 1987 Correlation between peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization. Obstetrics and Gynecology 70, 163-170.
28. Empson M, Lassere M, Craig J et al. 2005 Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database of Systematic Reviews 2005, Issue 4.
29. Ermel L, Marshburn P, Kutteh W 1995 Interaction of heparin with antiphospholipid antibodies from sera of women with recurrent pregnancy loss. American Journal of Reproductive Immunology 33, 14-20.
30. Franco RF, Trip MD, ten Cate H et al. 1999 The 20210 G→A mutation in the 3′ untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. British Journal of Haematology 104, 50-54.
31. Galli M, Comfurius P, Maassen C et al. 1990 Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet 335, 1544-1547.
32. Geva E, Amit A, Lerner-Geva L et al. 1995 Autoimmune disorders: another possible cause for in-vitro fertilization and embryo transfer failure. Human Reproduction 10, 2560-2563.
33. Geva E, Yaron Y, Lessing JB et al. 1994 Circulating autoimmune antibodies may be responsible for implantation failure in in-vitro-fertilization. Fertility and Sterility 62, 802-806.
34. Gleicher N 1997 Antiphospholipid antibodies and reproductive failure: what they do and what they don't do: how to, and how not to treat! Human Reproduction 12, 13-16.
35. Gleicher N, El-Roiey A 1988 The reproductive autoimmune failure syndrome. American Journal of Obstetrics and Gynecology 159, 223-227.
36. Gleicher N, Vidali A, Karande V 2002 The immunological 'War of the Roses': disagreements amongst reproductive immunologists. Human Reproduction 17, 539-542.
37. Gleicher N, Liu H, Dudkeiwicz A et al. 1994 Autoantibody profiles and immunoglobulin levels as predictors of IVF success. American Journal of Obstetrics and Gynecology 170, 1145-1149.
38. Gleicher N, El-Roeiy A, Confino E, Friberg J 1987 Autoantibodies in reproductive failure: is endometriosis an autoimmune disease? Obstetrics and Gynecology 70, 115-122.
39. Grandone E, Colaizzo D, Lo Bue A et al. 2001 Inherited thrombophilia and in vitro fertilization implantation failure. Fertility and Sterility 76, 201-202.
40. Hanly JG 2003 Antiphospholipid syndrome: an overview. Canadian Medical Association Journal 168, 1675-1682.
41. Harris EN 1990 The second international anticardiolipin standardization workshop/the Kingston antiphospholipid antibody study group. American Journal of Clinical Pathology 94, 476-484.
42. Harris EN, Gharavi AE, Hughes GR 1985 Anti-phospholipid antibodies. Clinics in Rheumatic Diseases 11, 591-609.
43. Harris EN, Gharavi AE, Boey ML et al. 1983 Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2, 1211-1214.
44. Hatasaka H 2000 Immunological factors in infertility. Clinical Obstetrics and Gynaecology 43, 830-843.
45. Hill J, Scott R 2000 Immunological tests and IVF: 'Please, enough already'. Fertility Sterility 74, 439-442.
46. Hornstein M, Davis O, Massey J et al. 2000 Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertility and Sterility 73, 330-333.
47. James JL, Stone PR, Chamley LW 2006 The regulation of trophoblast differentiation by oxygen in the first trimester of pregnancy. Human Reproduction Update 12, 137-144.
48. Kaider BD, Coulam CB, Roussev RG 1999 Murine embryos as a direct target for some human autuantibodies in vitro. Human Reproduction 14, 2556-2561.
49. Kallen CB, Arici A 2003 Immune testing in fertility practice: truth or deception? Current Opinion in Obstetrics and Gynaecology 15, 225-231.
50. Kowalik A, Vichnin M, Liu H et al. 1997 Midfollicular anticardiolipin and antiphosphatidylserine antibody titres do not correlate with in vitro fertilization outcome. Fertility and Sterility 68, 298-304.
51. Kutteh WH 1997 Antiphospholipid antibodies and reproduction. Journal of Reproductive Immunology 35, 151-171.
52. Kutteh WH 1996 Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low dose aspirin is superior to low dose aspirin alone. American Journal of Obstetrics and Gynecology 174, 1584-1589.
53. Kutteh WH, Yetman D, Chantilis S et al. 1997 Effect of antiphospholipid antibodies in women undergoing in vitro fertilization: role of heparin and aspirin. Human Reproduction 12, 1171-1175.
54. Li, DK, Liu L, Odouli R 2003 Exposure to non-steroidal antiinflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. British Medical Journal 327, 368-373.
55. Lockwood C, Romero R, Feinberg R et al. 1989 The prevalence and biological significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. American Journal of Obstetrics and Gynecology 161, 3369-3373.
56. 2 glycoprotein I dependent anticardiolipin antibody in early recurrent spontaneous abortion. Human Reproduction 12, 2140-2142.
57. Mak IY, Brosens JJ, Christian M et al. 2002 Regulated expression of signal transducer and activator of transcription, Stat5, and its enhancement of PRL expression in human endometrial stromal cells in vitro. Journal of Clinical Endocrinology and Metabolism 87, 2581-2588.
58. Martinelli I, Taioli E, Ragni G et al. 2003 Embryo implantation after assisted reproductive procedures and maternal thrombophilia. Haematologica 88, 789-793.
59. Matsuura E, Igarashi Y, Fujimoto M et al. 1990 Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336, 177-178.
60. Matzner W, Chong P, Xu G, Ching W 1994 Characterisation of antiphospholipid antibodies in women with recurrent spontaneous abortions. Journal of Reproductive Medicine 39, 27-30.
61. McIntyre JA, Wagenknecht DR 2000 Anti-phosphatidylethanolamine (aPE) antibodies: a survey. Journal of Autoimmunology 15, 185-193.
62. 2 glycoprotein I (apolipoprotein H). Proceedings of National Academy of Sciences of the USA 87, 4120-4124.
63. Mills JL, Simpson JL, Driscoll SG et al. 1988 Incidence of spontaneous abortion among normal women and insulin-dependant diabetic women whose pregnancies were identified within 21 days of conception. New England Journal of Medicine 319, 1617-1623.
64. Nielsen GL, Sorensen HT, Larsen H et al. 2001 Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. British Medical Journal 322, 266-270.
65. Out HJ, Bruinse HW, Derksen RH 1991 Anti-phospholipid antibodies and pregnancy loss. Human Reproduction 6, 889-897.
66. Parazzini F, Acaia B, Faden D et al. 1991 Antiphospholipid antibodies and recurrent abortion. Obstetrics and Gynaecology 77, 854-858.
67. Patrone C 1994 Aspirin as an antiplatelet drug. New England Journal of Medicine 330, 1287-1294.
68. Pattison NS, Chamley LW, Birdsall MA et al. 2000 Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomised controlled trial. American Journal of Obstetrics and Gynecology 183, 1008-1012.
69. Pauer HU, Neeson J, Hinney B 1998 Factor V leiden and its relevance in patients with recurrent abortion. American Journal of Obstetrics and Gynaecology 178, 629.
70. Petri M, Golbus M, Anderson R et al. 1998 Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of 44 women. Arthritis Rheumatology 30, 601-606.
71. Polzin WJ, Kopelman JN, Robinson RD et al. 1991 The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction. Obstetrics and Gynecology 78, 1108-1111.
72. Rai R, Cohen H, Davey M et al. 1997 Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with antiphospholipid antibodies. British Medical Journal 314, 253-257.
73. Rai RS, Regan L, Hadley E et al. 1996 Second trimester pregnancy loss is associated with activated protein C resistance. British Journal of Haematology 92, 489-490.
74. Rand JH, Wu XX, Quinn AS et al. 2003 Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. American Journal of Pathology 163, 1193-1200.
75. Rey E, Kahn S, David M et al. 2003 Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361, 901-908.
76. Roubey RA, Hoffman M 1997 From antiphospholipid syndrome to antibody-mediated thrombosis. Lancet 350, 1491-1492.
77. Salafia CM, Cowchock FS 1997 Placental pathology and antiphospholipid antibodies: a descriptive study. American Journal of Perinatology 14, 435-441.
78. Schenk L, Butler L, Morris JP et al. 1996 Heparin and aspirin treatment yields higher implantation rates in IVF patients with antiphospholipid antibody seropositivity compared to untreated seronegative patients (abstract). Proceedings from the Annual Meeting of the American Society for Reproductive Medicine, Boston, p. S39
79. Scott JR 2003 Immunotherapy for recurrent miscarriage. Cochrane Database of Systematic Reviews, Issue 1.
80. Seligsohn U, Zivelin A 1997 Thrombophilia as a multigenic disorder. Thrombosis Haemostasis 78, 297-301.
81. Sher G, Matzner W, Feinman M et al. 1998 The selective use of heparin/ aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in-vitro-fertilization. American Journal of Reproductive Immunology 40, 74-82.
82. Sher G, Feinman M, Zouves C et al. 1994 High fecundity rates following IVF and embryo transfer in antiphospholipid seropositive women treated with heparin and aspirin. Human Reproduction 9, 2278-2283.
83. Shurtz-Swirski R, Inbar O, Blank M et al. 1993 In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy. American Journal of Reproductive Immunology 29, 206-210.
84. Stern K, Kornman L, Norris H et al. 2003 Heparin/aspirin do not help antiphospholipid-positive women with recurrent spontaneous abortion. In: Abstracts Book for the 19th ESHRE Annual Meeting Madrid, 29 June-2 July 2003. Human Reproduction 18 (Suppl. 1, O-165), 57.
85. Stern C, Chamley L, Norris H et al. 2003 A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertility and Sterility 80, 376-383.
86. 2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertility and Sterility 70, 938-944.
87. Sthoeger ZM, Mozes E, Tartakovsky B 1993 Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proceedings of the National Academy of Sciences of the USA 90, 6464-6467.
88. Stirrat GM 1992 Recurrent spontaneous abortion. In: Coulam, CB, Faulk, WP, Mcintire JA (eds) Immunological Obstetrics. WW Norton and Company, New York, pp. 357-376.
89. Taylor PV, Campbell JM, Scott JS 1989 Presence of autoantibodies in women with unexplained infertility. American Journal of Obstetrics and Gynecology 161, 377-379.
90. Urman B, Yakin K, Balaban B 2005 Recurrent implantation failure inassisted reproduction: how to counsel and manage. B. Treatment options that have not been proven to benefit the couple. Reproductive BioMedicine Online 11, 382-391.
91. Van Horn JT, Craven C, Ward K et al. 2004. Features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 25, 642-648.
92. Wilson WA, Gharavi AE, Koike T et al. 1999 International Consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheumatology 42, 1309-1311.
93. Yasuda S, Bohgaki M, Atsumi T et al. 2005 Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway. Immunobiology 210, 775-780.
94. Yetman DL, Kutteh WH 1996 Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertility and Sterility 66, 540-546.
95. Yinon Y, Pauzner R, Dulitzky M et al. 2006 Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events. Reproductive BioMedicine Online 12, 354-358.
96. Younis JS, Ohel G, Brenner B et al. 1997 Familial thrombophilia - the scientific rationale for thromboprophylaxis. Human Reproduction 12, 1389-1390.